Changes in adverse events after multiple rituximab courses in patients with complicated steroid-dependent nephrotic syndrome

Clin Exp Nephrol. 2024 Mar;28(3):261-262. doi: 10.1007/s10157-023-02420-3. Epub 2023 Oct 21.

Authors

Toshimasa Morishita^{1

2}, Shuichiro Fujinaga³

Affiliations

¹ Division of Nephrology, Saitama Children's Medical Center, 1-2 Shintoshin, Chuo-Ku, Saitama-City, Saitama, 330-8777, Japan.
² Faculty of Medicine, Department of Pediatrics, Juntendo University, Tokyo, Japan.
³ Division of Nephrology, Saitama Children's Medical Center, 1-2 Shintoshin, Chuo-Ku, Saitama-City, Saitama, 330-8777, Japan. f_shuich@d2.dion.ne.jp.

PMID: 37864679
DOI: 10.1007/s10157-023-02420-3

No abstract available

Publication types

Letter

MeSH terms

Glucocorticoids / adverse effects
Humans
Immunologic Factors / adverse effects
Immunosuppressive Agents / adverse effects
Nephrotic Syndrome* / complications
Recurrence
Rituximab / adverse effects
Treatment Outcome

Substances

Rituximab
Immunologic Factors
Glucocorticoids
Immunosuppressive Agents